News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
FDA Approves New Indication for Novartis’ Leqvio® Allowing First-Line Use
Friday, August 01, 2025Novartis has announced that the US Food and Drug Administration FDA has approved an updated label for Leqvio inclisiran allowing it to be used as a firstline treatment The updated indication enables Leqvio
AstraZeneca and Revna Biosciences Broaden Access to Lung Cancer Treatment in Ghana
Thursday, July 31, 2025AstraZeneca and Revna Biosciences have made significant strides in improving lung cancer care in Ghana through their ongoing collaboration Since announcing their partnership in April both organisations have worked togethe
EuMentis Therapeutics Receives FDA Approval to Begin Phase 2 Trial of EM-221 for Schizophrenia
Thursday, July 31, 2025EuMentis Therapeutics a clinicalstage pharmaceutical company developing treatments for schizophrenia and other central nervous system CNS disorders has received clearance from the US Food and Drug Administration
Bio Usawa and Sartorius Stedim Biotech Partner to Advance Biopharmaceutical Manufacturing in Africa
Wednesday, July 30, 2025Bio Usawa Biotechnology Ltd an African biotechnology company has partnered with Sartorius Stedim Biotech a global biopharmaceutical manufacturing solutions provider to strengthen Africas biopharmaceutical sector
Calidi Biotherapeutics Granted FDA Fast Track Designation for CLD-201, an Innovative Viral Therapy for Soft Tissue Sarcoma
Wednesday, July 30, 2025Calidi Biotherapeutics Inc a clinicalstage biotechnology company focused on developing targeted treatments using genetic medicine delivery systems has received Fast Track designation from the US Food and Drug Administration FDA
Zymeworks Receives FDA Clearance for Investigational Drug ZW251 to Treat Liver Cancer
Tuesday, July 29, 2025Zymeworks Inc a clinicalstage biotechnology company has announced that the US Food and Drug Administration FDA has cleared its Investigational New Drug IND application for ZW
Boehringer Ingelheim and Re-Vana Therapeutics Partner to Develop Long-Acting Eye Treatments
Tuesday, July 29, 2025Boehringer Ingelheim has entered into a strategic collaboration and licensing agreement with ReVana Therapeutics a company based in the US and UK that specialises in ocular therapies and drug delivery technologies
Sarclisa Gains EU Approval for Newly Diagnosed Multiple Myeloma in Transplant-Eligible Patients
Friday, July 25, 2025Sanofi has received approval from the European Commission for the use of Sarclisa isatuximab in combination with bortezomib lenalidomide and dexamethasone VRd as an induction treatment for adults newly diagnosed
Candel Therapeutics Gains EMA Orphan Designation for CAN-2409 in Pancreatic Cancer Treatment
Friday, July 25, 2025Candel Therapeutics a clinicalstage biopharmaceutical company has been granted Orphan Designation by the European Medicines Agency EMA for its investigational therapy CAN aglatimagene besadenovec
Solid Biosciences Secures FDA Fast Track Designation for Gene Therapy Candidate SGT-501 Targeting CPVT
Thursday, July 24, 2025Solid Biosciences has received Fast Track designation from the US Food and Drug Administration FDA for SGT its investigational gene therapy for the treatment of catecholaminergic polymorphic ventricular tachycardia
